Source: Business Wire

Press Release: BioFlyte : BioFlyte Awarded SBIR Phase I Contract by U.S. Air Force to Advance its Aerosol Chem/Biothreat Detection and Identification Technology for Critical Infrastructure

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--BioFlyte has been awarded an AFWERX Small Business Innovation Research (SBIR) Phase I contract focused on its BioTOF z200

Read full article »

BioFlyte's Competitors | BioFlyte's News | BioFlyte's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Todd Sickles

CEO Approval Rating

86/100

BioFlyte is a New Mexico-based bioaerosol surveillance company that develops products such as biothreat detection and identification equipment for the healthcare industry.